APA
Click to copy
Schepp, F., Schubert, U., Schmid, J., Lehmann, S., Latunde-Dada, G. O., Kose, T., … Ludwig, B. (2023). Mechanistic Insights into Ferroptotic Cell Death in Pancreatic Islets. Hormone and Metabolic Research.
Chicago/Turabian
Click to copy
Schepp, Florian, Undine Schubert, Janine Schmid, Susann Lehmann, G. O. Latunde-Dada, Tugba Kose, C. Steenblock, Stefan R. Bornstein, A. Linkermann, and Barbara Ludwig. “Mechanistic Insights into Ferroptotic Cell Death in Pancreatic Islets.” Hormone and Metabolic Research (2023).
MLA
Click to copy
Schepp, Florian, et al. “Mechanistic Insights into Ferroptotic Cell Death in Pancreatic Islets.” Hormone and Metabolic Research, 2023.
BibTeX Click to copy
@article{florian2023a,
title = {Mechanistic Insights into Ferroptotic Cell Death in Pancreatic Islets},
year = {2023},
journal = {Hormone and Metabolic Research},
author = {Schepp, Florian and Schubert, Undine and Schmid, Janine and Lehmann, Susann and Latunde-Dada, G. O. and Kose, Tugba and Steenblock, C. and Bornstein, Stefan R. and Linkermann, A. and Ludwig, Barbara}
}
Abstract Ferroptosis was recently identified as a non-apoptotic, iron-dependent cell death mechanism that is involved in various pathologic conditions. There is first evidence for its significance also in the context of islet isolation and transplantation. Transplantation of pancreatic human islets is a viable treatment strategy for patients with complicated diabetes mellitus type 1 (T1D) that suffer from severe hypoglycemia. A major determinant for functional outcome is the initial islet mass transplanted. Efficient islet isolation procedures and measures to minimize islet loss are therefore of high relevance. To this end, better understanding and subsequent targeted inhibition of cell death during islet isolation and transplantation is an effective approach. In this study, we aimed to elucidate the mechanism of ferroptosis in pancreatic islets. Using a rodent model, isolated islets were characterized relating to the effects of experimental induction (RSL3) and inhibition (Fer1) of ferroptotic pathways. Besides viability, survival, and function, the study focused on characteristic ferroptosis-associated intracellular changes such as MDA level, iron concentration and the expression of ACSL4. The study demonstrates that pharmaceutical induction of ferroptosis by RSL3 causes enhancement of oxidative stress and leads to an increase of intracellular iron, zinc and MDA concentration, as well as the expression of ACSL4 protein. Consequently, a massive reduction of islet function, viability, and survival was found. Fer1 has the potential to inhibit and attenuate these cellular changes and thereby protect the islets from cell death.
